Two ‐year functional and anatomical results after converting treatment resistant eyes with exudative age‐related macular degeneration to aflibercept in accordance with a treat and extend protocol

ConclusionA majority of eyes showed improved anatomic outcomes. There was a small decrease in mean BCVA after the second year of treatment. About half of the eyes required treatment more frequently than the recommended aflibercept label of an 8‐week interval.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faos.13480

Source: Acta Ophthalmologica - May 1, 2017 Category: Opthalmology Authors: Øystein Kalsnes Jørstad, Rowan Thomas Faber, Morten Carstens Moe Tags: Original Article Source Type: research